0001213900-21-014908.txt : 20210311 0001213900-21-014908.hdr.sgml : 20210311 20210311173646 ACCESSION NUMBER: 0001213900-21-014908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210309 FILED AS OF DATE: 20210311 DATE AS OF CHANGE: 20210311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danenberg Noam CENTRAL INDEX KEY: 0001720898 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52545 FILM NUMBER: 21734437 MAIL ADDRESS: STREET 1: 4 BOROCHOV ST CITY: HOD HASHARON STATE: L3 ZIP: 4520404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wize Pharma, Inc. CENTRAL INDEX KEY: 0001218683 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880445167 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 HANAGAR ST CITY: HOD HASHARON STATE: L3 ZIP: 4527713 BUSINESS PHONE: 972 472 260 0536 MAIL ADDRESS: STREET 1: 24 HANAGAR ST CITY: HOD HASHARON STATE: L3 ZIP: 4527713 FORMER COMPANY: FORMER CONFORMED NAME: OphthaliX, Inc. DATE OF NAME CHANGE: 20120207 FORMER COMPANY: FORMER CONFORMED NAME: DENALI CONCRETE MANAGEMENT INC DATE OF NAME CHANGE: 20030213 4 1 ownership.xml X0306 4 2021-03-09 1 0001218683 Wize Pharma, Inc. WIZP 0001720898 Danenberg Noam C/O WIZE PHARMA, INC. 24 HANAGAR STREET HOD HASHARON L3 4527708 ISRAEL 1 1 0 0 Chief Executive Officer Common Stock, par value $0.001 per share 2021-03-09 4 P 0 2916667 0.12 A 3165705 D The Reporting Person resigned as Chief Executive Officer effective as of March 9, 2021. /s/ Noam Dannenberg 2021-03-11